106 related articles for article (PubMed ID: 2512186)
21. [PUVA therapy: long-term degenerative effects. II. Study of ultrastructural changes in the skin induced by PUVA therapy].
Torras H; Bombi JA
Med Cutan Ibero Lat Am; 1987; 15(3):179-84. PubMed ID: 3312860
[TBL] [Abstract][Full Text] [Related]
22. [The risks of photochemotherapy (author's transl)].
Stüttgen G; Kentsch V; Schalla W; Schneider L
Z Hautkr; 1981 Nov; 56(21):1379-99. PubMed ID: 6458954
[TBL] [Abstract][Full Text] [Related]
23. Ocular side effects of PUVA-treated patients refusing eye sun protection.
Calzavara-Pinton PG; Carlino A; Manfredi E; Semeraro F; Zane C; De Panfilis G
Acta Derm Venereol Suppl (Stockh); 1994; 186():164-5. PubMed ID: 8073824
[TBL] [Abstract][Full Text] [Related]
24. PUVA treatment and skin cancer: A follow-up study.
Lassus A; Reunala T; Idänpää-Heikkilä J; Juvakoski T; Salo O
Acta Derm Venereol; 1981; 61(2):141-5. PubMed ID: 6165190
[TBL] [Abstract][Full Text] [Related]
25. Randomized, double-blind comparison of 1 mg/L versus 5 mg/L methoxsalen bath-PUVA therapy for chronic plaque-type psoriasis.
Vongthongsri R; Konschitzky R; Seeber A; Treitl C; Hönigsmann H; Tanew A
J Am Acad Dermatol; 2006 Oct; 55(4):627-31. PubMed ID: 17010742
[TBL] [Abstract][Full Text] [Related]
26. 8-MOP PUVA for psoriasis: a comparison of a minimal phototoxic dose-based regimen with a skin-type approach.
Collins P; Wainwright NJ; Amorim I; Lakshmipathi T; Ferguson J
Br J Dermatol; 1996 Aug; 135(2):248-54. PubMed ID: 8881668
[TBL] [Abstract][Full Text] [Related]
27. Comparison of trioxsalen bath and oral methoxsalen PUVA in psoriasis.
Turjanmaa K; Salo H; Reunala T
Acta Derm Venereol; 1985; 65(1):86-8. PubMed ID: 2578716
[TBL] [Abstract][Full Text] [Related]
28. The effectiveness of PUVA treatment in severe psoriasis is significantly increased by additional UV 308-nm excimer laser sessions.
Trott J; Gerber W; Hammes S; Ockenfels HM
Eur J Dermatol; 2008; 18(1):55-60. PubMed ID: 18086590
[TBL] [Abstract][Full Text] [Related]
29. Minimising the risks of PUVA treatment.
van Praag MC; Tseng LN; Mommaas AM; Boom BW; Vermeer BJ
Drug Saf; 1993 May; 8(5):340-9. PubMed ID: 8504016
[TBL] [Abstract][Full Text] [Related]
30. [Treatment of plaque-type psoriasis with cream-PUVA therapy].
Steinmeyer K; Grundmann-Kollmann M; Podda M; Kaufmann R
Hautarzt; 2001 Oct; 52(10):885-7. PubMed ID: 17690819
[TBL] [Abstract][Full Text] [Related]
31. Skin cancers or premalignant lesions occur in half of high-dose PUVA patients.
Lever LR; Farr PM
Br J Dermatol; 1994 Aug; 131(2):215-9. PubMed ID: 7917985
[TBL] [Abstract][Full Text] [Related]
32. Risk of skin tumors in psoralen- and ultraviolet A-treated patients.
Henseler T; Christophers E
Natl Cancer Inst Monogr; 1984 Dec; 66():217-9. PubMed ID: 6531033
[TBL] [Abstract][Full Text] [Related]
33. [The Koebner phenomenon, a prognostic sign of PUVA therapy effectiveness in patients with psoriasis vulgaris--yes or no?].
Matović L; Poljacki M; Duran V; Stojanović S; Subotić M
Med Pregl; 1999; 52(11-12):437-40. PubMed ID: 10748764
[TBL] [Abstract][Full Text] [Related]
34. [Studies on the PUVA (psoralen plus UVA) therapy of psoriasis. II. Histological findings of the treated skin (author's transl)].
Kumakiri M; Ohnuki M; Koguchi K; Kato N; Tachibana N; Miura Y
Nihon Hifuka Gakkai Zasshi; 1980 Oct; 90(11):1003-8. PubMed ID: 6970278
[No Abstract] [Full Text] [Related]
35. The ultraviolet fingerprint dominates the mutational spectrum of the p53 and Ha-ras genes in psoralen + ultraviolet A keratoses from psoriasis patients.
Wolf P; Kreimer-Erlacher H; Seidl H; Bäck B; Soyer HP; Kerl H
J Invest Dermatol; 2004 Jan; 122(1):190-200. PubMed ID: 14962108
[TBL] [Abstract][Full Text] [Related]
36. Actinic degeneration in association with long-term use of PUVA.
Stern RS; Parrish JA; Fitzpatrick TB; Bleich HL
J Invest Dermatol; 1985 Feb; 84(2):135-8. PubMed ID: 3968447
[TBL] [Abstract][Full Text] [Related]
37. Cutaneous and ocular side-effects of oral photochemotherapy: results of an 8-year follow-up study.
Cox NH; Jones SK; Downey DJ; Tuyp EJ; Jay JL; Moseley H; Mackie RM
Br J Dermatol; 1987 Feb; 116(2):145-52. PubMed ID: 3828211
[TBL] [Abstract][Full Text] [Related]
38. Early dermato-pathological signs during bath-PUVA therapy.
Piérard-Franchimont C; Nickels-Read D; Ben Mosbah T; Arrese Estrada J; Piérard GE
J Pathol; 1990 Jul; 161(3):227-31. PubMed ID: 1975271
[TBL] [Abstract][Full Text] [Related]
39. Cutaneous carcinoma and PUVA lentigines in Thai patients treated with oral PUVA.
Gritiyarangsan P; Sindhavananda J; Rungrairatanaroj P; Kullavanijaya P
Photodermatol Photoimmunol Photomed; 1995 Aug; 11(4):174-7. PubMed ID: 8850252
[TBL] [Abstract][Full Text] [Related]
40. Evidence for CD8+ cell increase in long-term PUVA-treated psoriatic patients after PUVA discontinuation.
Borroni G; Zaccone C; Vignati G; Fietta A; Merlini C; Rabbiosi G
Dermatology; 1992; 185(1):69-71. PubMed ID: 1638076
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
